On September 19, 2019, the U.S. Food and Drug Administration (FDA) issued four draft guidances and updated a final guidance related to the Safety and Performance Based Pathway as part of our commitment to strengthening and modernizing the 510(k) program, as described in the FDA’s Medical Device Safety Action Plan.
As a first step to operationalizing the Safety and Performance Based Pathway, the FDA issued four draft guidances that identify performance criteria and testing methodologies for certain devices within four class II device types:
Webinar on this guidance
On November 7, 2019, the FDA will host a webinar on the Safety and Performance Based Pathway guidances for industry and others interested in learning more about these guidances. Registration is not necessary.
No hay comentarios:
Publicar un comentario